Vaccination against human papillomavirus (HPV) infection has proved to reduce the incidence of cervical cancer by nearly 90%. Research into all aspects of HPV-related disease continues as the following examples illustrate.
Immunodiagnosis and immunotherapeutics based on human papillomavirus for HPV-induced cancers
Dong Z, Hu R, Du Y et al.
Front Immunol 2021 Jan 8; 11: 586796. doi: 10.3389/fimmu.2020.586796. eCollection 2020.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.